Paul E. Sax

Vigorous HIV-1-Specific CD4 ⁺ T Cell Responses Associated with Control of Viremia

Eric Rosenberg, James M. Billingsley, Angela M. Caliendo et al. · Science · 1997 · 1.8K citations

Life Sciences, Immunology, Infectious Diseases +14

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Paul E. Sax, Kristine M. Erlandson, Jordan E. Lake et al. · Clinical Infectious Diseases · 2019 · 750 citations · Full text

Public Health, Pharmacotherapy, Clinical Epidemiology +15

Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy

Colleen Hadigan, James B. Meigs, Colleen Corcoran et al. · Clinical Infectious Diseases · 2001 · 680 citations

Medicine, Nutritional Sciences, Human Nutrition +16

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

Huldrych F. Günthard, Michael S. Saag, Constance A. Benson et al. · JAMA · 2016 · 656 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Paul E. Sax, David A. Wohl, Michael T. Yin et al. · The Lancet · 2015 · 598 citations

Pharmacy, Pharmacology, Pharmacotherapy +17